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Abstract
Background: According to the Word Health Organization, patients who can benefit from palliative care should be
identified earlier to enable proactive palliative care. Up to now, this is not common practice and has hardly been
addressed in scientific literature. Still, palliative care is limited to the terminal phase and restricted to patients with
cancer. Therefore, we trained general practitioners (GPs) in identifying palliative patients in an earlier phase of their
disease trajectory and in delivering structured proactive palliative care. The aim of our study is to determine if this
training, in combination with consulting an expert in palliative care regarding each palliative patient’s tailored care
plan, can improve different aspects of the quality of the remaining life of patients with severe chronic diseases
such as chronic obstructive pulmonary disease, congestive heart failure and cancer.
Methods/Design: A two-armed randomized controlled trial was performed. As outcome variables we studied:
place of death, number of hospital admissions and number of GP out of hours contacts.
Discussion: We expect that this study will increase the number of identified palliative care patients and improve
different aspects of quality of palliative care. This is of importance to improve palliative care for patients with
COPD, CHF and cancer and their informal caregivers, and to empower the GP. The study protocol is described and
possible strengths and weaknesses and possible consequences have been outlined.
Trial Registration: The Netherlands National Trial Register: NTR2815
Background
According to the World Health Organization (WHO)
palliative care is ‘an approach that improves the quality
of life of patients and their families facing the problems
associated with life-threatening illness, through the pre-
vention and relief of suffering by means of early identifi-
cation and impeccable assessment and treatment of pain
and other problems, physical, psychosocial and spiritual’
[1]. A first challenge evoked by this definition is the
early identification of a patient who may benefit from
palliative care. Although the WHO-recommendations
have been accepted worldwide, no scientific papers have
been published yet on how to identify patients who
could potentially benefit from an earlier start of a pallia-
tive care in general practice. A literature review of
Qaseem et al. did not identify any validated tools that
predict the optimal timing to initiate palliative care ser-
vices in general practice,[2] despite the fact that a lot of
research has been undertaken to elucidate the prediction
of mortality, survival, and prognostication for patients
with advanced cancer and non-cancer diseases [3-10].
For patients not recognized as being in a palliative
phase an individualized well-considered plan of action is
missing [11,12].
Several illness trajectories have been described for peo-
ple with progressive chronic illnesses [13,14]. For none of
these trajectories the right moment to start palliative care
has been defined yet. Particularly regarding patients with
non-malignant diseases, such as advanced chronic
obstructive pulmonary disease (COPD) and congestive
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heart failure (CHF), recognizing or defining the moment
when palliative care should be taken in consideration
seems difficult (Figure 1) [15,16]. In a national question-
naire among multiple palliative care providers the lack of
prognostic indicators and clinical triggers for starting end
of life care appeared to be the most important missing
link in applying palliative care in primary care [17]. By
integrating palliative care into curative care practices or
combining palliative care with disease-oriented manage-
ment earlier in the disease trajectory, chronically ill
patients nearing the end of life reported improved satis-
faction with care and demonstrated less acute interven-
tions and were more likely to die at home [18,19].
The second challenge in bringing the WHO definition
into clinical practice, for which early identification is a pre-
requisite, is a structured proactive palliative care planning.
Palliative care programs appeared to reduce symptom
distress and improve patient and family satisfaction.
Important elements of structured proactive palliative care
proved to be coaching the patient to make choices regard-
ing future interventions or restrictions,[20-22] consulting
caregivers,[18] eliciting values and addressing the psycho-
logical, existential and social context of patient and infor-
mal caregiver [23,24]. By proactive planning death at
home could be enhanced, [25-27] the number of unfore-
seen transfers decreased,[28] hospital lengths of stay and
aggressive interventions diminished and consequently
costs and utilization decreased [28-30].
For GPs a structured proactive palliative care planning is
a challenge, as patients with an advanced chronic disease
are often under supporting care of the disease-specific spe-
cialists until far in the disease trajectory [31]. The GPs
should pick up their role as coordinator of palliative care
against the mainstream of disease-oriented interventions
[32,33]. Several studies concluded that when a GP is part
of a team, palliative care improves on different aspects; for
patient, informal carer and the participating GP [34,35].
Aims of the study
Research questions
In this study we aim to answer the following questions:
Does early identification and proactive palliative care
planning of palliative patients by the GP influence
1. Place of death, number of transitions and number
of contacts with the out of hours primary care
service?
2. Quality of life of patients and their informal care-
givers and prescriptions?
3. GP satisfaction with the delivered palliative care
and their own assessment of their ability to provide
palliative care?
The objective of this report is to present the study pro-
tocol used for the data collection in 2009 and 2010. We
describe the protocol of the study, provide a description of
the intervention, the methodology and the baseline char-
acteristics of the participating GPs. The described metho-
dology will also serve as a reference for future publications
about this study.
Methods/Design
Study design
We performed a two-armed randomized controlled trial.
We studied the following hypothesis: H0: training GPs
in early identification of palliative care patients and
proactive care planning will not increase the percentage
of patients that die at home, will not reduce the amount
of hospital admissions and will not reduce the number of
contacts with the out of hours primary care service. This
high
palliativecare
followupcare
informal
caregiver
karnofskyͲscore

intensity
‘interference’
generalpractitioner
low
death
time
terminalphasediagnosis stablephase
?? ?
momentofidentification
Figure 1 What is the moment to start palliative care?, a modified figure of Lynn and Adamson [37].
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hypothesis will be rejected if the training has a significant
positive effect on these aspects of care.
Power calculation
Sample size was based on number of contacts with the
out of hours primary care service. To detect a difference
between the intervention and the control group with a
power of 80% and an alpha error of 0.05 minimum sam-
ple size was 96 patients in both groups when 20%
reduction in out of hours contacts was considered.
Participants
GPs in two comprehensive cancer centre (IKO and IKZ)
regions in the South-East of the Netherlands were invited
by mail to participate in the study. After one month a
reminder was send to non-responders. Excluded were GPs
who are consultant in palliative care or who are locum.
GPs that wanted to participate were stratified for degree of
urbanization and working hours (part-time or full-time)
and were randomized assigned to the intervention or the
control condition by an independent statistician. To pre-
vent contamination, those GPs working together in the
same practice were placed in the same study group.
Ethical considerations
The study was conducted after approval of the research
ethics committee of the Radboud University Nijmegen
Medical Centre in accordance with the Medical Research
Involving Human Subjects Acts (WMO). Patient and
physician anonymity was guaranteed throughout the
registration and data entry process. Patients and their
informal caregiver were invited to participate by their
GP. If they agreed to participate in the longitudinal study
they received a patient information letter and an
informed consent form. Trial registration has been
obtained. (The Netherlands National Trial Register:
NTR2815)
The intervention
The intervention for the GPs in the experimental condi-
tion consisted of three consecutive parts.
Part one consisted of a five-hours training in early
identification of palliative patients and proactive care
planning. This training was provided by two experienced
GPs with a specialization in palliative care and an
extended experience in teaching. Early identification was
based on two tools, developed in an earlier stage of the
project and described elsewhere (submitted). The first
tool is a plasticized card (Table 1) with indicators to
identify and recognize patients with respectively COPD,
CHF and cancer as being in a stage that palliative care
should be considered, the so-called ‘Radboud Indicators
Palliative Care Needs’ (RADPAC). GPs were trained in 1)
checking actual problems of the patient in a structured
way at the moment of identification, 2) considering
potential problems that could be expected in the (near)
future and 3) foretelling the most likely scenarios on
deterioration and death. A previously developed tool
(Table 2) could be used as an abstract of the content of
the training and could be used to structure the discussion
Table 1 The RADboud indicators of PAlliative Care needs (RADPAC)
Congestive Heart Failure 1. The patient has severe limitations, experiences symptoms even while at rest. Mostly bedbound patients. (NYHA IV)
2. There were frequent hospital admissions (> 3 per year)
3. The patient has frequent exacerbations of severe heart failure (> 3 per year)
4. The patient is moderately disabled; dependent. Requires considerable assistance and frequent care
(Karnofsky-score ≤ 50%)
5. The patient increases in weight what is not responding to increased dose of diuretics
6. A general deterioration of the clinical situation (oedema, orthopnoe, nycturie, dyspnoea)
7. The patient mentions ‘end of life approaching’
Chronic Obstructive
Pulmonary Disease
1. The patient is moderately disabled; dependent. Requires considerable assistance and frequent care
(Karnofsky-score ≤ 50%)
2. The patient has substantial weight loss (± 10% loss of bodyweight in six months)
3. The presence of congestive heart failure
4. The patient has orthopnoe
5. The patient mentions ‘end of life approaching’
6. There are objective signs of serious dyspnoea (decreased dyspnoea d’ effort, dyspnoea with speaking, use of
respiratory assistant muscles and orthopnoe)
Cancer 1. Patient has a primary tumour with a poor prognosis
2. Patient is moderately disabled; dependent. Requires considerable assistance and frequent care
(Karnofsky-score ≤ 50%)
3. There is a progressive decline in physical functioning
4. The patient is progressively bedridden
5. The patient has a diminished food intake
6. The presence of progressive weight loss
7. The presence of the anorexie-cachexie syndrome
(lack of appetite, general weakness, emaciating, muscular atrophy)
8. The patient has a diminished ‘drive to live’
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with the patient and their informal caregiver, and to
explore their actual en potential problems and needs
(Proactive Palliative Care Planning Card (PPCPC)). The
aim was a shared proactive policy to deliver specific,
proper and individualized palliative care planning.
The second part of the intervention consisted of a
coaching session for the GPs with a physician specia-
lized in palliative care regarding each identified patient
included in the study. In this session the GP received
feedback and suggestions on the proposed proactive pal-
liative care plan, potential future problems and potential
scenarios of deterioration and death.
The third part of the intervention consisted of two
peer group sessions of the intervention GPs, eight and
ten months after the initial training session. In these
sessions the main focus was patient-GP communication
techniques regarding having the first conversation with
the patient about palliative care (and thus about end of
life issues). GPs also had the opportunity to exchange
experiences on this topic. Data for process description
were collected during the first year after T0. Effect eva-
luation took place in April 2011.
Control group
GPs in the control group were asked to provide usual
care. They were not trained and had no access to RAD-
PAC, nor to the PPCPC. Consultation by telephone with
the palliative care helpdesk of the Comprehensive Can-
cer Centre was possible as usual. This service is available
24/7 for all GPs in the two comprehensive cancer centre
regions in the South-East of the Netherlands; mostly
these consultations are on problems in the terminal
phase for which the GP needs specialised advice for
acute problems. For GPs in the control group a training
will be organized after the intervention study is closed.
Data collection
At the start of the study (t = 1), GPs in the intervention
group were asked to use RADPAC to screen the medical
records of all patients in their practice to identify patients
with COPD, CHF or cancer who potentially could benefit
from a palliative care approach. They were instructed to
continue to use RADPAC each time new data of a patient
with CHF, COPD or progressive cancer was available. In
2011, anonymous data were collected retrospectively
from the medical records of all patients that had a non-
acute death during the intervention period, as well in the
intervention as in the control practices (t = 2). All
deceased patients who were diagnosed with CHF, COPD
and/or cancer were included (Figure 2). Each non-
planned (out of hour) contact and hospital or nursing
home admission during the study was derived from the
medical record and registered as well as place of death
and if the patient had been identified as being in the pal-
liative trajectory. Besides, qualitative data were collected
concerning proactive care planning in both study groups.
Outcomes
GPs of both study groups were invited to extract data of
all patients that died during the observational period
from the medical records: demographics, disease history,
place of death, hospital admissions and out of hours
consultations. Of each participating GP, demographic
characteristics, practice characteristics and their interest
in palliative care were collected (Table 3).
Data management and plan of statistical analysis
All data were entered in a database and analysed with
SPSS 16.0. In both study groups, all patients who died
during the inclusion and observation period of the study
of a non-acute death, were included in the retrospective
Table 2 Reminder for proactive planning and disease specific potential problems
Somatic domain Social en financial domain
Policy Policy
Actual problems: Actual problems:
Expected problems:
Scenario of dying:
Expected problems:
Care provision and activity of daily living Sense of meaning and psychological domain
Policy Policy
Actual problems: Actual problems:
Expected problems: Expected problems:
Possible future problems
Pain, Dyspnoe, Ileus, Delirium, Fear, Depression, Coma, Liver/renal failure
Strain of informal caregiver, Special technical care
Disease specific interest
CHF: anaemia switch of the defibrillator weight
COPD: medicinal/non-medicinal possibilities against dyspnoea
(Proactive Palliative Care Planning Card, PPCPC)
Thoonsen et al. BMC Family Practice 2011, 12:123
http://www.biomedcentral.com/1471-2296/12/123
Page 4 of 7
analysis. Intervention and control group will be com-
pared on the main outcomes (place of death, number of
transitions and out of hours contact, amount of identi-
fied patients). Recruitment rates and drop-out rates will
be calculated. In case denominators prove to be signifi-
cantly correlated with the outcome of the main study
question, an Anova will be performed to identify poten-
tial related or independent factors. Multilevel analysis
will be performed.
Discussion
The present study has been designed to assess the effects
of training GPs in early identification and a proactive pal-
liative care approach regarding patients with COPD, CHF
or cancer.
Strengths
Up to now, hardly any data are available about imple-
menting the 2002 WHO-definition for palliative care. To
our knowledge this is the first intention to treat RCT that
assesses the effect of training GPs in early identification
and using a proactive holistic palliative care approach,
which are the main aspects of this definition. The train-
ing for the GPs in the intervention group was standar-
dised and piloted, to minimize differences between the
two trainers and to be available for future courses. The
tools that the GPs in the intervention group could use
for helping to identify palliative patients in an earlier
stage than usual and to structure the proactive care plan-
ning, were developed in a scientifically sound way.
Results will be published in peer-reviewed scientific jour-
nals and will be communicated to relevant clinician
associations.
Weaknesses
Those GPs that were interested to take part in the study,
probably have a special interest in palliative care. Besides,
as there is a lot of attention for proactive palliative care
in medical journals and in Dutch policy, GPs in the con-
trol group might be influenced by new information or
followed courses. This implies that it might be difficult to
find significant differences between intervention and con-
trol group. As patients were identified by their own GP,
we were not able to influence this process directly.
We did not choose to collect prospective patient data
in the control group, as this would be a sort of interven-
tion. Therefore, effect measurement took place retro-
spectively. GPs in both intervention and control group
were asked to collect retrospective data from their digi-
tal patient information system. This implies that we do
not have patient data of non-responding GPs.
We performed a multifaceted intervention: a combina-
tion of training GPs and offering them tools to facilitate
early identification and proactive care planning. Usually,
multifaceted interventions are more effective than single
interventions,[36] but the relative impact of each com-
ponent of the intervention cannot be established.
Conclusion
The present study will increase the knowledge about the
effect of training GPs in early identification and a proac-
tive palliative care approach. This knowledge is of
importance to improve palliative care for patients with
COPD, CHF and cancer and their informal caregivers,
as well as to empower the GP. Here, the study protocol
is described and possible strengths and weaknesses and
possible consequences have been outlined.
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Figure 2 Study design randomized controlled trial.
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